{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:20:36Z","timestamp":1763986836892,"version":"3.41.2"},"reference-count":17,"publisher":"FapUNIFESP (SciELO)","issue":"11","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20230727","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T12:48:54Z","timestamp":1696855734000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae"],"prefix":"10.1590","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-3254","authenticated-orcid":false,"given":"U\u011fur","family":"\u00d6nal","sequence":"first","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-3509","authenticated-orcid":false,"given":"Nazmiye \u00dclk\u00fc","family":"T\u00fczemen","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-8245","authenticated-orcid":false,"given":"P\u0131nar K\u00fc\u00e7\u00fckdemirci","family":"Kaya","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8111-5958","authenticated-orcid":false,"given":"Remzi","family":"\u0130\u015f\u00e7imen","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-1632","authenticated-orcid":false,"given":"Nermin Kelebek","family":"Girgin","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-3630","authenticated-orcid":false,"given":"C\u00fcneyt","family":"\u00d6zak\u0131n","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4820-2288","authenticated-orcid":false,"given":"Ferda \u015e\u00f6hret","family":"Kahveci","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-1279","authenticated-orcid":false,"given":"Halis","family":"Akal\u0131n","sequence":"additional","affiliation":[{"name":"Uludag University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study","volume":"22","author":"Wang M","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12879-021-06253-x","article-title":"The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies","volume":"21","author":"Savoldi A","year":"2021","journal-title":"BMC Infect Dis"},{"year":"2023","series-title":"National healthcare safety network (NHSN) patient safety component manual","key":"ref3"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.12659\/MSM.905919","article-title":"Prognostic risk factors in ventilator-associated pneumonia","volume":"24","author":"Karakuzu Z","year":"2018","journal-title":"Med Sci Monit"},{"year":"2023","series-title":"People who are immunocompromised","key":"ref5"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"915.e1","DOI":"10.1016\/j.cmi.2021.01.001","article-title":"External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients","volume":"27","author":"Papadimitriou-Olivgeris M","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European society of clinical microbiology and \u0131nfectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul M","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2013.09.010","article-title":"Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing gram-negative bacteria","volume":"43","author":"Pontikis K","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"ref9","first-page":"1","article-title":"Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae","author":"Aysert-Yildiz P","year":"2022","journal-title":"J Chemother"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jac\/dky406","article-title":"Fosfomycin in severe infections due to genetically distinct pan-drug-resistant Gram-negative microorganisms: synergy with meropenem","volume":"74","author":"Perdig\u00e3o Neto LV","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac121","article-title":"Effect of ceftazidime\/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study","volume":"4","author":"Oliva A","year":"2022","journal-title":"JAC Antimicrob Resist"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/1120009X.2020.1745501","article-title":"In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and\/or NDM-producing Klebsiella pneumoniae","volume":"32","author":"Erturk Sengel B","year":"2020","journal-title":"J Chemother"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2019-0074","article-title":"Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence","volume":"6","author":"Bakthavatchalam YD","year":"2020","journal-title":"Future Sci OA"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/1120009X.2021.1963618","article-title":"In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases in the carbapenem-resistant groups","volume":"34","author":"Zarakolu P","year":"2022","journal-title":"J Chemother"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.5005\/jp-journals-10071-23958","article-title":"A real-world study on prescription pattern of fosfomycin in critical care patients","volume":"25","author":"Zirpe KG","year":"2021","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-022-04425-4","article-title":"Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting","volume":"41","author":"Isler B","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/dkl251","article-title":"Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration","volume":"58","author":"Gattringer R","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302023001100600&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:02:04Z","timestamp":1730289724000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302023001100600&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023]]}},"alternative-id":["S0104-42302023001100600"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20230727","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e20230727"}}